Crossmark

Correction: NCAPD2 is a favorable predictor of prognostic and immunotherapeutic biomarker for multiple cancer types including lung cancer

Crossref DOI link: https://doi.org/10.1186/s41021-024-00301-z

Published Online: 2024-02-13

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Feng, Linyuan

Yang, Yang

Lin, Zhenhua

Cui, Minghua

Jin, Aihua

Cui, Aili https://orcid.org/0000-0002-4741-2972
License Information

Text and Data Mining valid from 2024-02-13

Version of Record valid from 2024-02-13
More Information

Article History

First Online: 13 February 2024